The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Policy Call 23rd May
1) CTF GA Workshop
To discuss proposed CTF consultation strategy. 1st draft here.
Reference GA Agenda item 17.2 here.
See also AAHP GA statement feedback here.
2) Catch up from recent meetings
RP:
– Cytotoxic exposure event in the EP. More information here.
– FIPRA Biosimilar event (Plus EGA request. More information here.)
– European Commission Professional Regulation event. More information here.
– Meeting with Slovak Presidency on medicines shortages
(To also discuss Supply Chain Actors statement. Recent RP comments here.)
– Off label call
– FMD call
JP:
– ESOP
– EAPT
3) Invitations
To discuss PGEU-EAHP meeting. More information here.
Invitation to French residents meeting. More information here.
Invitation to 20 June FIPRA pricing event. More information here.
4) Week ahead
Finalising GA workshop documentation ahead of shipment
Reviewing member feedback on GA statements and making final drafts
Preparing next week’s shortages presentation plus assisting TMG and RM on upcoming meetings
Follow ups from recent meetings (see above)
Preparing GA presentation materials
5) Monitoring
More information here.
(RP to give verbal explanation)